Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Neuron
|
March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases
Muhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 27, 2026
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins
Raquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, et al.
Nature Genetics
|
November 11, 2024
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease
Daniel Western, Jigyasha Timsina, Lihua Wang, et al.
Molecular Psychiatry
|
June 11, 2021
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease
Mary Ann A DeMichele-Sweet, Lambertus Klei, Byron Creese, et al.
Research Square
|
August 13, 2025
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification
Sathyaseelan Chakkarai, Michal Sadowski, Qiong Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Basic Science and Pathogenesis
Ting-Chen Wang, Jigyasha Timsina, Chenyang Jiang, et al.
Research Square
|
July 16, 2024
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
Stephanie Debette, Ilana Caro, Daniel Western, et al.
Nature Aging
|
November 20, 2025
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
Ilana Caro, Daniel Western, Shinichi Namba, et al.
Nature Medicine
|
July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
Farhad Imam, Rowan Saloner, Jacob W Vogel, et al.
Acta Neuropathologica
|
March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Luca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Neuron
|
March 31, 2026
Large-scale CSF and plasma proteomics reveal immune, synaptic, and extracellular matrix disruptions across neurodegenerative diseases
Muhammad Ali, Jigyasha Timsina, Ying Xu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 27, 2026
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins
Raquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, et al.
Nature Genetics
|
November 11, 2024
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease
Daniel Western, Jigyasha Timsina, Lihua Wang, et al.
Molecular Psychiatry
|
June 11, 2021
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease
Mary Ann A DeMichele-Sweet, Lambertus Klei, Byron Creese, et al.
Research Square
|
August 13, 2025
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratification
Sathyaseelan Chakkarai, Michal Sadowski, Qiong Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Basic Science and Pathogenesis
Ting-Chen Wang, Jigyasha Timsina, Chenyang Jiang, et al.
Research Square
|
July 16, 2024
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
Stephanie Debette, Ilana Caro, Daniel Western, et al.
Nature Aging
|
November 20, 2025
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease
Ilana Caro, Daniel Western, Shinichi Namba, et al.
Nature Medicine
|
July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
Farhad Imam, Rowan Saloner, Jacob W Vogel, et al.
Acta Neuropathologica
|
March 14, 2020
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Luca Kleineidam, Vincent Chouraki, Tomasz Próchnicki, et al.
Page
of 10